Diagnosis, treatment and prognosis of hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus (Review)
- Authors:
- Yinchuan Xia
- Junqi Zhang
- Xiaoling Ni
-
Affiliations: Department of Oncology, Bazhong Central Hospital, Bazhong, Sichuan 636000, P.R. China - Published online on: August 7, 2020 https://doi.org/10.3892/ol.2020.11962
- Article Number: 101
-
Copyright: © Xia et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Georgen M, Regimbeau JM, Kianmanesh R, Marty J, Farges O and Belghiti J: Removal of hepatocellular carcinoma extending in the right atrium without extracorporal bypass. J Am Coll Surg. 195:892–894. 2002. View Article : Google Scholar : PubMed/NCBI | |
Lee I, Chung JW, Kim HC, Yin YH, So YH, Jeon UB, Jae HJ, Cho BH and Park JH: Extrahepatic collateral artery supply to the tumor thrombi of hepatocellular carcinoma invading inferior vena cava: The prevalence and determinant factors. J Vasc Interv Radiol. 20:22–29. 2009. View Article : Google Scholar : PubMed/NCBI | |
Okuda K: Hepatocellular carcinoma: Clinicopathological aspects. J Gastroenterol Hepatol. 12:S314–S318. 1997. View Article : Google Scholar : PubMed/NCBI | |
Zhang ZM, Lai EC, Zhang C, Yu HW, Liu Z, Wan BJ, Liu LM, Tian ZH, Deng H, Sun QH and Chen XP: The strategies for treating primary hepatocellular carcinoma with portal vein tumor thrombus. Int J Surg. 20:8–16. 2015. View Article : Google Scholar : PubMed/NCBI | |
Kudo M, Iznmi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O, Kojiro M and Makuuchi M; HCC Expert Panel of Japan Society of Hepatology, : Management of hepatocellular carcinoma in Japan: Consensus-based clinical practice guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis. 29:339–364. 2011. View Article : Google Scholar : PubMed/NCBI | |
Chun YH, Ahn SH, Park JY, Kim DY, Han KH, Chon CY, Byun SJ and Kim SU: Clinical characteristics and treatment outcomes of hepatocellular carcinoma with inferior vena cava/heart invasion. Anticancer Res. 31:4641–4646. 2011.PubMed/NCBI | |
Wang Y, Yuan L, Ge RL, Sun Y and Wei G: Survival benefit of surgical treatment for hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus: Results of a retrospective cohort study. Ann Surg Oncol. 20:914–922. 2013. View Article : Google Scholar : PubMed/NCBI | |
Sonsuz A: Barcelona clinic liver cancer (BCLC) staging: Does it cover all our expectation. J Gastrointest Cancer. 48:260–261. 2017. View Article : Google Scholar : PubMed/NCBI | |
Sakamoto K and Nagano H: Outcomes of surgery for hepatocellular carcinoma with tumor thrombus in the inferior vena cava or right atrium. Surg Today. 48:819–824. 2018. View Article : Google Scholar : PubMed/NCBI | |
Sun JH, Zhang YL, Nie CH, Chen LM, He JD, Wang WL and Zheng SS: Long-term survival after chemoembolization of metastatic right atrial tumor thrombus as a presenting feature of hepatocellular carcinoma: A case study. Oncol Lett. 3:975–977. 2012. View Article : Google Scholar : PubMed/NCBI | |
Kawakami M, Koda M, Mandai M, Hosho K, Murawaki Y, Oda W and Hayashi K: Isolated metastases of hepatocellular carcinoma in the right atrium: Case report and review of the literature. Oncol Lett. 5:1505–1508. 2013. View Article : Google Scholar : PubMed/NCBI | |
Ohwada S, Tanahashi Y, Kawashima Y, Satoh Y, Nakamura S, Kobayashi I, Ohya T, Ishikawa S, Ohtaki A, Iino Y, et al: Surgery for tumor thrombi in the right atrium and inferior vena cava of patients with recurrent hepatocellular carcinoma. Hepatogastroenterology. 41:154–157. 1994.PubMed/NCBI | |
Nakashima T, Okuda K, Kojiro M, Jimi A, Yamaguchi R, Sakamoto K and Ikari T: Pathology of hepatocellular carcinoma in Japan. 232 Consecutive cases autopsied in ten years. Cancer. 51:863–877. 1983. View Article : Google Scholar : PubMed/NCBI | |
Kojiro M, Nakahara H, Sugihara S, Murakami T, Nakashima T and Kawasaki H: Hepatocellular carcinoma with intra-atrial tumor growth. A clinicopathologic study of 18 autopsy cases. Arch Pathol Lab Med. 108:989–992. 1984.PubMed/NCBI | |
Anthony PP: Primary carcinoma of the liver: A study of 282 cases in Ugandan Africans. J Pathol. 110:37–48. 1973. View Article : Google Scholar : PubMed/NCBI | |
Edmondson HA and Steiner PE: Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies. Cancer. 7:462–503. 1954. View Article : Google Scholar : PubMed/NCBI | |
Macdonald RA: Primary carcinoma of the liver; a clinicopathologic study of one hundred eight cases. Ama Arch Intern Med. 99:266–279. 1957. View Article : Google Scholar : PubMed/NCBI | |
Koo J, Fung K, Siu KF, Lee NW, Lett Z, Ho J, Wong J and Ong GB: Recovery of malignant tumor cells from the right atrium during hepatic resection for hepatocellular carcinoma. Cancer. 52:1952–1956. 1983. View Article : Google Scholar : PubMed/NCBI | |
Sung AD, Cheng S, Moslehi J, Scully EP, Prior JM and Loscalzo J: Hepatocellular carcinoma with intracavitary cardiac involvement: A case report and review of the literature. Am J Cardiol. 102:643–645. 2008. View Article : Google Scholar : PubMed/NCBI | |
Cheng HY, Wang XY, Zhao GL and Chen D: Imaging findings and transcatheter arterial chemoembolization of hepatic malignancy with right atrial embolus in 46 patients. World J Gastroenterol. 14:3563–3568. 2008. View Article : Google Scholar : PubMed/NCBI | |
Miyayama S, Matsui O, Taki K, Minami T, Ryu Y, Ito C, Nakamura K, Inoue D, Notsumata K, Toya D, et al: Extrahepatic blood supply to hepatocellular carcinoma: Angiographic demonstration and transcatheter arterial chemoembolization. Cardiovasc Intervent Radiol. 29:39–48. 2006. View Article : Google Scholar : PubMed/NCBI | |
Tse HF, Lau CP, Lau YK and Lai CL: Transesophageal echocardiography in the detection of inferior vena cava and cardiac metastasis in hepatocellular carcinoma. Clin Cardiol. 19:211–213. 1996. View Article : Google Scholar : PubMed/NCBI | |
Okada S: How to manage hepatic vein tumour thrombus in hepatocellular carcinoma. J Gastroenterol Hepatol. 15:346–348. 2000. View Article : Google Scholar : PubMed/NCBI | |
Asahara T, Itamoto T, Katayama K, Nakahara H, Hino H, Yano M, Ono E, Dohi K, Nakanishi T, Kitamoto M, et al: Hepatic resection with tumor thrombectomy for hepatocellular carcinoma with tumor thrombi in the major vasculatures. Hepatogastroenterology. 46:1862–1869. 1999.PubMed/NCBI | |
Komatsu S, Kido M, Asari S, Toyama H, Ajiki T, Demizu Y, Terashima K, Okimoto T, Sasaki R and Fukumoto T: Particle radiotherapy, a novel external radiation therapy, versus liver resection for hepatocellular carcinoma accompanied with inferior vena cava tumor thrombus: A matched-pair analysis. Surgery. 162:1241–1249. 2017. View Article : Google Scholar : PubMed/NCBI | |
Li AJ, Zhou WP, Lin C, Lang XL, Wang ZG, Yang XY, Tang QH, Tao R and Wu MC: Surgical treatment of hepatocellular carcinoma with inferior vena cava tumor thrombus: A new classification for surgical guidance. Hepatobiliary Pancreat Dis Int. 12:263–269. 2013. View Article : Google Scholar : PubMed/NCBI | |
Miyazaki M, Ito H, Nakagawa K, Shimizu H, Yoshidome H, Shimizu Y, Ohtsuka M, Togawa A and Kimura F: An approach to intrapericardial inferior vena cava through the abdominal cavity, without median sternotomy, for total hepatic vascular exclusion. Hepatogastroenterology. 48:1443–1446. 2001.PubMed/NCBI | |
Mizuno S, Kato H, Azumi Y, Kishiwada M, Hamada T, Usui M, Sakurai H, Tabata M, Shimpo H and Isaji S: Total vascular hepatic exclusion for tumor resection: A new approach to the intrathoracic inferior vena cava through the abdominal cavity by cutting the diaphragm vertically without cutting the pericardium. J Hepatobiliary Pancreat Sci. 17:197–202. 2010. View Article : Google Scholar : PubMed/NCBI | |
Wakayama K, Kamiyama T, Yokoo H, Kakisaka T, Kamachi H, Tsuruga Y, Nakanishi K, Shimamura T, Todo S and Taketomi A: Surgical management of hepatocellular carcinoma with tumor thrombi in the inferior vena cava or right atrium. World J Surg Oncol. 11:2592013. View Article : Google Scholar : PubMed/NCBI | |
Bi X, Gao J and Cai J: Sorafenib versus transarterial chemoembolization as adjuvant therapies for patients with hepatocellular carcinoma and microvascular invasion. J Clin Oncol. 37 (Suppl 4):S2442019. View Article : Google Scholar | |
Li J, Hou Y, Cai XB and Liu B: Sorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma. World J Gastroenterol. 22:4034–4040. 2016. View Article : Google Scholar : PubMed/NCBI | |
Li Z, Gao J, Zheng SM, Wang Y, Xiang X, Cheng Q and Zhu J: The efficacy of sorafenib in preventing hepatocellular carcinoma recurrence after resection: A systematic review and meta-analysis. Rev Esp Enferm Dig. 112:201–210. 2020. View Article : Google Scholar : PubMed/NCBI | |
Wang L, Ke Q, Lin N, Zeng Y and Liu J: Does postoperative adjuvant transarterial chemoembolization benefit for all patients with hepatocellular carcinoma combined with microvascular invasion: A meta-analysis. Scand J Gastroenterol. 54:528–537. 2019. View Article : Google Scholar : PubMed/NCBI | |
Zhang XP, Liu YC, Chen ZH, Sun JX, Wang K, Chai ZT, Shi J, Guo WX, Wu MC, Lau WY and Cheng SQ: Postoperative adjuvant transarterial chemoembolization improves outcomes of hepatocellular carcinoma associated with hepatic vein invasion: A propensity score matching analysis. nn Surg Oncol. 26:1465–1473. 2019. View Article : Google Scholar | |
Uemoto K, Doi H, Shiomi H, Yamada K, Tatsumi D, Yasumoto T, Takashina M, Koizumi M and Oh RJ: Clinical assessment of micro-residual tumors during stereotactic body radiation therapy for hepatocellular carcinoma. Anticancer Res. 38:945–954. 2018.PubMed/NCBI | |
Kokudo T, Hasegawa K, Yamamoto S, Shindoh J, Takemura N, Aoki T, Sakamoto Y, Makuuchi M, Sugawara Y and Kokudo N: Surgical treatment of hepatocellular carcinoma associated with hepatic vein tumor thrombosis. J Hepatol. 61:583–588. 2014. View Article : Google Scholar : PubMed/NCBI | |
Kokudo T, Hasegawa K, Matsuyama Y, Takayama T, Izumi N, Kadoya M, Kudo M, Kubo S, Sakamoto M, Nakashima O, et al: Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: A Japanese nationwide survey. Hepatology. 66:510–517. 2017. View Article : Google Scholar : PubMed/NCBI | |
Kouloulias V, Mosa E, Georgakopoulos J, Platoni K, Brountzos I, Zygogianni A, Antypas C, Kosmidis P, Mystakidou K, Tolia M, et al: Three-dimensional conformal radiotherapy for hepatocellular carcinoma in patients unfit for resection, ablation, or chemotherapy: A retrospective study. ScientificWorldJournal. 2013:7801412013. View Article : Google Scholar : PubMed/NCBI | |
Rim CH, Kim CY, Yang DS and Yoon WS: External beam radiation therapy to hepatocellular carcinoma involving inferior vena cava and/or right atrium: A meta-analysis and systemic review. Radiother Oncol. 129:123–129. 2018. View Article : Google Scholar : PubMed/NCBI | |
Matsuo Y, Yoshida K, Nishimura H, Ejima Y, Miyawaki D, Uezono H, Ishihara T, Mayahara H, Fukumoto T, Ku Y, et al: Efficacy of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis/inferior vena cava tumor thrombosis: Evaluation by comparison with conventional three-dimensional conformal radiotherapy. J Radiat Res. 57:512–523. 2016. View Article : Google Scholar : PubMed/NCBI | |
Edge SB and Compton CC: The American joint committee on cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010. View Article : Google Scholar : PubMed/NCBI | |
Komatsu S, Fukumoto T, Demizu Y, Miyawaki D, Terashima K, Niwa Y, Mima M, Fujii O, Sasaki R, Yamada I, et al: The effectiveness of particle radiotherapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus. J Gastroenterol. 46:913–920. 2011. View Article : Google Scholar : PubMed/NCBI | |
Hou JZ, Zeng ZC, Zhang JY, Fan J, Zhou J and Zeng MS: Influence of tumor thrombus location on the outcome of external-beam radiation therapy in advanced hepatocellular carcinoma with macrovascular invasion. Int J Radiat Oncol Biol Phys. 84:362–368. 2012. View Article : Google Scholar : PubMed/NCBI | |
Doi H, Beppu N, Kitajima K and Kuribayashi K: Stereotactic body radiation therapy for liver tumors: Current status and perspectives. Anticancer Res. 38:591–599. 2018.PubMed/NCBI | |
Chern MC, Chuang VP, Chern MC, Lin ZH and Lin YM: Erratum to: Transcatheter arterial chemoembolization for advanced hepatocellular carcinoma with inferior vena cava and right atrial tumors. Cardiovasc Intervent Radiol. 32:13212009. View Article : Google Scholar | |
Chung SM, Yoon CJ, Lee SS, Hong S, Chung JW, Yang SW, Seong NJ, Jang ES, Kim JW and Jeong SH: Treatment outcomes of transcatheter arterial chemoembolization for hepatocellular carcinoma that invades hepatic vein or inferior vena cava. Cardiovasc Intervent Radiol. 37:1507–1515. 2014. View Article : Google Scholar : PubMed/NCBI | |
Koo JE, Kim JH, Lim YS, Park SJ, Won HJ, Sung KB and Suh DJ: Combination of transarterial chemoembolization and three-dimensional conformal radiotherapy for hepatocellular carcinoma with inferior vena cava tumor thrombus. Int J Radiat Oncol Biol Phys. 78:180–187. 2010. View Article : Google Scholar : PubMed/NCBI | |
Sengodan P, Grewal H and Gandhi S: Invasive hepatocellular carcinoma with recurrent pulmonary embolism: Use of AngioVac cannula thrombectomy device for mechanical aspiration. J Invasive Cardiol. 26:E100–E103. 2014.PubMed/NCBI | |
Nishikawa H, Kita R, Kimura T and Osaki Y: Transcatheter arterial embolic therapies for hepatocellular carcinoma: A literature review. Anticancer Res. 34:6877–6886. 2014.PubMed/NCBI | |
Chang JY, Ka WS, Chao TY, Liu TW, Chuang TR and Chen LT: Hepatocellular carcinoma with intra-atrial tumor thrombi. A report of three cases responsive to thalidomide treatment and literature review. Oncology. 67:320–326. 2004. View Article : Google Scholar : PubMed/NCBI | |
Stotz M, Gerger A, Haybaeck J, Kiesslich T, Bullock MD and Pichler M: Molecular targeted therapies in hepatocellular carcinoma: Past, present and future. Anticancer Res. 35:5737–5744. 2015.PubMed/NCBI | |
Simão A, Silva R, Correia L, Caseiro Alves F, Carvalho A and Nascimento Costa JM: Advanced stage hepatocellular carcinoma with multiple metastasis and vascular thrombosis: A case of complete response to sorafenib. Acta Med Port. 29:139–142. 2016. View Article : Google Scholar : PubMed/NCBI | |
Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, Luo R, Feng J, Ye S, Yang TS, et al: Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: A phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol. 10:25–34. 2009. View Article : Google Scholar : PubMed/NCBI | |
Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, et al: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 359:378–390. 2008. View Article : Google Scholar : PubMed/NCBI | |
Li W, Wang Y, Gao W and Zheng J: HCC with tumor thrombus entering the right atrium and inferior vena cava treated by percutaneous ablation. BMC Surg. 17:212017. View Article : Google Scholar : PubMed/NCBI | |
Duan F, Yu W, Wang Y, Liu FY, Song P, Wang ZJ, Yan JY, Yuan K and Wang MQ: Trans-arterial chemoembolization and external beam radiation therapy for treatment of hepatocellular carcinoma with a tumor thrombus in the inferior vena cava and right atrium. Cancer Imaging. 15:72015. View Article : Google Scholar : PubMed/NCBI | |
Yang QH, Zhang W, Liu QX, Liu LX, Wu LL, Wang JH, Yan ZP and Luo JJ: TACE combined with implantation of irradiation stent versus TACE combine with bare stent for HCC complicated by IVCTT. Cardiovasc Intervent Radiol. 39:1280–1288. 2016. View Article : Google Scholar : PubMed/NCBI | |
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI | |
Jun CH, Sim DW, Kim SH, Hong HJ, Chung MW, Cho SB, Park CH, Joo YE, Kim HS, Choi SK and Rew JS: Risk factors for patients with stage IVB hepatocellular carcinoma and extension into the heart: Prognostic and therapeutic implications. Yonsei Med J. 55:379–386. 2014. View Article : Google Scholar : PubMed/NCBI | |
Minagawa M, Ikai I, Matsuyama Y, Yamaoka Y and Makuuchi M: Staging of hepatocellular carcinoma: Assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg. 245:909–922. 2007. View Article : Google Scholar : PubMed/NCBI | |
Daniele B, Annunziata M, Barletta E, Tinessa V and Di Maio M: Cancer of the Liver Italian Program (CLIP) score for staging hepatocellular carcinoma. Hepatol Res. 37 (Suppl 2):S206–S209. 2007. View Article : Google Scholar : PubMed/NCBI | |
Liu J, Wang Y, Zhang D, Liu B and Ou Q: Comparison of survival and quality of life of hepatectomy and thrombectomy using total hepatic vascular exclusion and chemotherapy alone in patients with hepatocellular carcinoma and tumor thrombi in the inferior vena cava and hepatic vein. Eur J Gastroenterol Hepatol. 24:186–94. 2012. View Article : Google Scholar : PubMed/NCBI | |
Igaki H, Nakagawa K, Shiraishi K, Shiina S, Kokudo N, Terahara A, Yamashita H, Sasano N, Omata M and Ohtomo K: Three-dimensional conformal radiotherapy for hepatocellular carcinoma with inferior vena cava invasion. Jpn J Clin Oncol. 38:438–444. 2008. View Article : Google Scholar : PubMed/NCBI | |
Kim HC, Lee JH, Chung JW, Kang B, Yoon JH, Kim YJ, Lee HS, Jae HJ and Park JH: Transarterial chemoembolization with additional cisplatin infusion for hepatocellular carcinoma invading the hepatic vein. J Vasc Interv Radiol. 24:274–283. 2013. View Article : Google Scholar : PubMed/NCBI |